AR012896A1 - HELICOBACTER PYLORI FLGE POLYPEPTIDE, VACCINE COMPOSITION, USE OF SUCH POLYPEPTIDE FOR THE MANUFACTURE OF COMPOSITIONS, INVITRO DIAGNOSTIC METHOD AND DIAGNOSTIC KIT FOR THE DETECTION OF HELICOBACTER PYLORI INFECTION - Google Patents

HELICOBACTER PYLORI FLGE POLYPEPTIDE, VACCINE COMPOSITION, USE OF SUCH POLYPEPTIDE FOR THE MANUFACTURE OF COMPOSITIONS, INVITRO DIAGNOSTIC METHOD AND DIAGNOSTIC KIT FOR THE DETECTION OF HELICOBACTER PYLORI INFECTION

Info

Publication number
AR012896A1
AR012896A1 ARP980102558A ARP980102558A AR012896A1 AR 012896 A1 AR012896 A1 AR 012896A1 AR P980102558 A ARP980102558 A AR P980102558A AR P980102558 A ARP980102558 A AR P980102558A AR 012896 A1 AR012896 A1 AR 012896A1
Authority
AR
Argentina
Prior art keywords
helicobacter pylori
polypeptide
compositions
manufacture
detection
Prior art date
Application number
ARP980102558A
Other languages
Spanish (es)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of AR012896A1 publication Critical patent/AR012896A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56922Campylobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un polipéptido FlgE de Helicobacter pylori, o su forma modificada que retiene antigenicidad funcionalmente equivalente, para uso en la induccion deuna respuesta inmune protectora a la infeccion de Helicobacter pylori, composicion de vacuna, uso de dicho polipéptido para la fabricacion decomposiciones, método de diagnostico in vitro y kit de diagnostico para la deteccion de la infeccion por Helicobacter pylori.A Helicobacter pylori FlgE polypeptide, or its modified form that retains functionally equivalent antigenicity, for use in inducing a protective immune response to Helicobacter pylori infection, vaccine composition, use of said polypeptide for the manufacture of compositions, diagnostic method in vitro and diagnostic kit for the detection of Helicobacter pylori infection.

ARP980102558A 1997-06-12 1998-06-01 HELICOBACTER PYLORI FLGE POLYPEPTIDE, VACCINE COMPOSITION, USE OF SUCH POLYPEPTIDE FOR THE MANUFACTURE OF COMPOSITIONS, INVITRO DIAGNOSTIC METHOD AND DIAGNOSTIC KIT FOR THE DETECTION OF HELICOBACTER PYLORI INFECTION AR012896A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702242A SE9702242D0 (en) 1997-06-12 1997-06-12 Vaccine compositions V

Publications (1)

Publication Number Publication Date
AR012896A1 true AR012896A1 (en) 2000-11-22

Family

ID=20407351

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102558A AR012896A1 (en) 1997-06-12 1998-06-01 HELICOBACTER PYLORI FLGE POLYPEPTIDE, VACCINE COMPOSITION, USE OF SUCH POLYPEPTIDE FOR THE MANUFACTURE OF COMPOSITIONS, INVITRO DIAGNOSTIC METHOD AND DIAGNOSTIC KIT FOR THE DETECTION OF HELICOBACTER PYLORI INFECTION

Country Status (21)

Country Link
EP (1) EP1009764A1 (en)
JP (1) JP2002507118A (en)
KR (1) KR20010013699A (en)
CN (1) CN1259960A (en)
AR (1) AR012896A1 (en)
AU (1) AU8048798A (en)
BR (1) BR9810026A (en)
CA (1) CA2293293A1 (en)
EE (1) EE9900566A (en)
HU (1) HUP0003164A3 (en)
ID (1) ID23052A (en)
IL (1) IL133144A0 (en)
IS (1) IS5288A (en)
NO (1) NO996132L (en)
NZ (1) NZ501427A (en)
PL (1) PL337503A1 (en)
SE (1) SE9702242D0 (en)
SK (1) SK173099A3 (en)
TR (1) TR199903060T2 (en)
WO (1) WO1998056816A1 (en)
ZA (1) ZA984696B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784687A (en) * 2015-04-27 2015-07-22 苏州大学附属第一医院 Application of flagellar hook protein FlgE of reorganized pseudomonas aeruginosa
CN113425717B (en) * 2021-04-22 2023-06-16 成都欧林生物科技股份有限公司 Medicament for improving efficacy of oral helicobacter pylori vaccine and application thereof
CN116535472B (en) * 2023-05-31 2024-04-30 四川大学华西医院 Helicobacter pylori recombinant protein antigen FlgK and preparation method and application thereof
CN118105473B (en) * 2024-04-30 2024-08-16 成都欧林生物科技股份有限公司 Oral immunogenic composition for preventing or treating Hp infection and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
AR003125A1 (en) * 1995-06-01 1998-07-08 Astra Ab BACTERIAL ANTIGENS FOR THE DIAGNOSIS OF INFECTIONS WITH HELICOBACTER PYLORI, A DNA MOLECLE THAT CODES IT, A VECTOR, A HOST CELL, A PROCEDURE FOR PRODUCING THE POLIPEPTIDE, USE OF ELEPIPETICO, AND PROAPILY USE

Also Published As

Publication number Publication date
HUP0003164A2 (en) 2000-12-28
IL133144A0 (en) 2001-03-19
SE9702242D0 (en) 1997-06-12
AU8048798A (en) 1998-12-30
BR9810026A (en) 2000-09-19
TR199903060T2 (en) 2000-09-21
NO996132D0 (en) 1999-12-10
KR20010013699A (en) 2001-02-26
HUP0003164A3 (en) 2001-10-29
PL337503A1 (en) 2000-08-28
CA2293293A1 (en) 1998-12-17
EP1009764A1 (en) 2000-06-21
JP2002507118A (en) 2002-03-05
ZA984696B (en) 1999-01-04
ID23052A (en) 2000-01-20
EE9900566A (en) 2000-06-15
SK173099A3 (en) 2000-06-12
WO1998056816A1 (en) 1998-12-17
CN1259960A (en) 2000-07-12
NZ501427A (en) 2000-09-29
NO996132L (en) 2000-01-28
IS5288A (en) 1999-12-08

Similar Documents

Publication Publication Date Title
TR200403064T2 (en) Methods and compounds for the diagnosis and prevention of tuberculosis by immunotherapy.
ES2176232T3 (en) ADEQUATE VACCINE TO BE USED IN THE PREVENTION AND TREATMENT OF INFECTION WITH HELICOBACTER.
CO5210894A1 (en) ASSISTANT COMPOSITIONS THAT INCLUDE AN ALUMINUM SALT AND AN IMMUNO STIMULANT
MX9304089A (en) USE OF GM-CSF AS AN ADJUVANT VACCINE.
GB2303855B (en) Helicobacter pylori antigenic protein preparation and immunoassays
ES2062355T3 (en) PHARMACEUTICAL COMPOSITION INCLUDING LORATADINE, IBUPROPHEN AND PSEUDOEFEDRINE.
AR003006A1 (en) COMPOSITION OF A COMBINED VACCINE INCLUDING A CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE B CONJUGATED WITH A CARRIER PROTEIN ADSORBED ON ALUMINUM PHOSPHATE AND ONE OR OTHER DIFFERENT ANTIGENS FOR A DIFFERENT PRODUCTION
CO5700790A2 (en) VACCINE COMPOSITIONS THAT INCLUDE AN INTERLEUCINE 18 AND SAPONINA ASSISTANT SYSTEM
ES2184769T3 (en) METHODS AND COMPOSITIONS FOR MICROENCAPSULATION OF ANTIGENS TO USE AS VACCINES.
NO991524L (en) vaccinations
ATE329617T1 (en) ANTIGEN-CONTAINING COMPOSITION ADDITIONALLY CONTAINING DERIVATIZED MONOGLYCERIDES OR DIGLYCERIDES AS ADJUVANTS
MX9400166A (en) VEGETABLE PROTEIN MICROSPHERES, HYDROLYZED, MODIFIED AND METHODS FOR THEIR PREPARATION AND USE.
DK0528859T3 (en) Oral vaccine which includes antigen attached to the surface of red blood cells
PT1171143E (en) PHARMACEUTICAL OR COSMETIC OR NUTRACEUTICAL COMPOSITION FOR A PRIMARY EXTRACT OF TREMOCH AND PHARMACEUTICAL OR NUTRACEUTIC COMPOSITION UNDERSTANDING THE ABOVE EXTRACT
DE3852761D1 (en) SAPONINE TOOLS.
ATE223702T1 (en) METHOD AND COMPOSITIONS FOR MICROCAPSULATING ADJUVANTS
AU4195897A (en) Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof
MX24890A (en) SYNTHETIC POLYPEPTIDE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT.
AR012896A1 (en) HELICOBACTER PYLORI FLGE POLYPEPTIDE, VACCINE COMPOSITION, USE OF SUCH POLYPEPTIDE FOR THE MANUFACTURE OF COMPOSITIONS, INVITRO DIAGNOSTIC METHOD AND DIAGNOSTIC KIT FOR THE DETECTION OF HELICOBACTER PYLORI INFECTION
ATE375514T1 (en) COMPOSITIONS AND METHODS FOR DETECTING TRYPANOSOMA CRUZI INFECTION
ES2308850T3 (en) ANTIBODIES FOR ANTIGENS OF CELLS OF LANGERHANS OF MAMIFEROS AND ITS USES.
ES2079851T3 (en) USE OF IL-4 TO IMPROVE THE IMMUNE RESPONSE AGAINST IMMUNOGEN IN VACCINES.
DK0451688T3 (en) Powdered dental embedding masses with improved flow properties
DE69637435D1 (en) SAPONIN COMPOSITIONS AND ITS USE
BR0013574A (en) Old Moraxella Vaccine

Legal Events

Date Code Title Description
FB Suspension of granting procedure